Disclosed herein are cannabinoid receptor ligands of formula (I) ##STR00001## wherein Y, X.sup.1, X.sup.2, X.sup.3, R.sup.1, and R.sup.2 are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.